Isolere Bio

company

About

Isolere Bio is a Healthcare Company.

  • 11 - 50

Details

Last Funding Type
Grant
Last Funding Money Raised
$0.90M
Industries
Biotechnology,Health Care,Therapeutics
Founded date
Jan 1, 2017
Number Of Employee
11 - 50
Operating Status
Active

Monoclonal antibodies make up an effective and rapidly growing class of drugs. They are also critical research tools and essential for the development of many new diagnostics. Isolere Bio was co-founded with the vision of simplifying and streamlining the purification of biotherapeutics to improve global access to these important drugs.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$1.17M
Isolere Bio has raised a total of $1.17M in funding over 2 rounds. Their latest funding was raised on Feb 17, 2022 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Feb 17, 2022 Grant $0.90M 1 National Science Foundation Detail
Jan 31, 2019 Grant $269.99K 1 National Science Foundation Detail

Investors

Number of Lead Investors
Number of Investors
2
1
Isolere Bio is funded by 1 investors. National Science Foundation are the most recent investors.
Investor Name Lead Investor Funding Round
National Science Foundation Yes Grant